Provided by Tiger Trade Technology Pte. Ltd.

Crescent Biopharma Inc

16.89
+0.12000.72%
Post-market: 16.84-0.0500-0.30%19:30 EDT
Volume:3.12M
Turnover:52.88M
Market Cap:627.36M
PE:-2.28
High:17.87
Open:16.67
Low:16.15
Close:16.77
52wk High:27.41
52wk Low:8.72
Shares:37.14M
Float Shares:15.95M
Volume Ratio:7.55
T/O Rate:19.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4105
EPS(LYR):-12.8150
ROE:-160.75%
ROA:-69.15%
PB:8.65
PE(LYR):-1.32

Loading ...

Crescent's Tumor Treatment Validated by Akeso Trial Results, Wedbush Says

MT Newswires Live
·
Sep 15

Wedbush Remains a Buy on Crescent Biopharma (CBIO)

TIPRANKS
·
Sep 14

Crescent Biopharma Price Target Maintained with a $27.00/Share by Wedbush

Dow Jones
·
Sep 14

Crescent Biopharma Price Target Maintained with a $27.00/Share by Wedbush

Dow Jones
·
Aug 27

Crescent Biopharma Grants Employee Stock Options for 19,425 Shares at $14.47 Each

Reuters
·
Aug 03

Crescent Biopharma Q2 EPS $(0.74) Beats $(0.79) Estimate

Benzinga Earnings
·
Jul 30

Crescent Biopharma Q2 FY26 Net Loss Widens to $24.8 Million

Reuters
·
Jul 30

Crescent Biopharma - Multiple Key Clinical Data Readouts Expected Beginning in Q1 2027

THOMSON REUTERS
·
Jul 30

Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

THOMSON REUTERS
·
Jul 30

Crescent Biopharma Grants Inducement Stock Options for 52,500 Shares at $15.83 Each

Reuters
·
Jul 24

Fairmount Healthcare Fund II LP Acquires 853,450 Crescent Biopharma Shares for $12.38 Million

Reuters
·
Jul 21

Crescent Biopharma Issues Pre-funded Warrants for 525,897 Shares in $143.7 Million Offering

Reuters
·
Jul 17

Press Release: Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Dow Jones
·
Jul 17

Crescent Biopharma Prices $125 Million Common, Warrant Offering

MT Newswires Live
·
Jul 15

Crescent Biopharma Inc: Prices Its Underwritten Public Offering of 8,094,793 Ordinary Shares at $14.50 Per Share

THOMSON REUTERS
·
Jul 15

Crescent Biopharma Inc: Pre-funded Warrants are Being Sold at a Price to the Public of $14.499 Per Pre-funded Warrant

THOMSON REUTERS
·
Jul 15

Press Release: Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-funded Warrants

Dow Jones
·
Jul 15

Crescent Biopharma Dips on Planned Equity Raise

Reuters
·
Jul 15

Crescent Biopharma Launches Offering of Common Shares, Warrants

MT Newswires Live
·
Jul 15

Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-funded Warrants

THOMSON REUTERS
·
Jul 15